Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2005

01-09-2005 | Concise Article

Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature

Authors: T. Hannu, L. Mattila, H. Rautelin, A. Siitonen, M. Leirisalo-Repo

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2005

Login to get access

Abstract

Presented here are three cases of acute cardiac disease (myocarditis, myopericarditis, and acute atrial fibrillation) associated with Campylobacter jejuni infection, followed by a review of the corresponding literature. Since Campylobacter jejuni is the most common cause of human bacterial enteritis in developed countries, these cases emphasize the importance of keeping cardiac complications in mind when treating patients with acute gastroenteritis due to this pathogen.
Literature
1.
2.
3.
Pönkä A, Pitkänen T, Pettersson T, Aittoniemi S, Kosunen TU (1980) Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand 208:495–496PubMedCrossRef
4.
Florkowski CM, Ikram RB, Crozier IM, Ikram H, Berry ME (1984) Campylobacter jejuni myocarditis. Clin Cardiol 7:558–559PubMedCrossRef
5.
Melby K, von der Lippe E, Bruun JN (1992) Myokarditt og perikarditt i forbindelse med infeksjon med Campylobacter jejuni [with summary in English]. Tidsskr Nor Lægeforen 112:475–476PubMed
6.
Sanchez JF, Lalinde L, Fernandez Capitan C, Pacios E (1992) Diarrea por Campylobacter jejuni y miopericarditis. An Med Interna 9:102–103PubMed
7.
Williams A (1997) First the chicken, then the egg; the heartburn came later. Med Health R I 80:163–165PubMed
8.
Douchet MP, Dugast S, Zupan M, Christmann D (1999) Myopéricardite à Campylobacter jejuni. Presse Medicale 28:1237
9.
Sauvant G, Bossart W, Kurrer MO, Follath F (2000) Diagnose und Verlauf bei Myokarditis: eine Erhebung in den Medizinischen Kliniken des Universitätsspitals Zûrich im Zeitraum von 1980 bis 1998 [with summary in English]. Schweiz Med Wochenschr 130:1265–1271PubMed
10.
Cox ID, Fluck DS, Joy MD (2001) Campylobacter myocarditis; loose bowels and a baggy heart. Eur J Heart Fail 3:105–107CrossRefPubMed
11.
Westling K, Evengard B (2001) Myocarditis associated with Campylobacter infection. Scand J Infect Dis 33:877–878CrossRefPubMed
12.
Wanby P, Olsen B (2001) Myocarditis in a patient with salmonella and campylobacter enteritis. Scand J Infect Dis 33:860–862CrossRefPubMed
13.
Cunningham C, Lee CH (2003) Myocarditis related to Campylobacter jejuni infection: a case report. BMC Infect Dis 3:16CrossRefPubMed
14.
Kell RJA, Ellis ME (1985) Transient atrial fibrillation in Campylobacter jejuni infection. BMJ 291:1542
15.
Rafi J, Matz J (2002) An unusual case of Campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia. Ann Allergy Asthma Immunol 89:362–367PubMedCrossRef
16.
Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A, Leirisalo-Repo M (2002) Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) 41:312–318CrossRef
17.
Rautelin H, Hänninen M-L (2000) Campylobacters: the most common bacterial enteropathogens in the Nordic countries. Ann Med 32:440–445PubMed
18.
Altekruse SF, Stern NJ, Fields PI, Swerdlow DL (1999) Campylobacter jejuni – an emerging foodborne pathogen. Emerg Infect Dis 5:28–35PubMedCrossRef
19.
Skirrow MB, Blaser MJ (2000) Clinical aspects of infection. In: Nachamkin I, Blaser MJ (eds) Campylobacter. ASM, Washington, DC, pp 69–88
20.
Hannu T, Sihto-Kauppi K, Kotaniemi K, Kauppi M (2004) Acute anterior uveitis in association with an outbreak of Campylobacter jejuni infection. Scand J Rheumatol 33:55–57PubMedCrossRef
Metadata
Title
Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature
Authors
T. Hannu
L. Mattila
H. Rautelin
A. Siitonen
M. Leirisalo-Repo
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-0001-2

Other articles of this Issue 9/2005

European Journal of Clinical Microbiology & Infectious Diseases 9/2005 Go to the issue

Article

Rapid decrease of free vancomycin in dense staphylococcal cultures

Concise Article

Linezolid treatment of ventriculoperitoneal shunt infection without implant removal

Concise Article

Cytomegalovirus cholangitis presenting with recurrent hemobilia

Concise Article

Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens

Review

Treatment of severe acute respiratory syndrome

Concise article

Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits